496 results on '"Duthie, Malcolm S."'
Search Results
2. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
3. Mycobacterium leprae induces Schwann cell proliferation and migration in a denervated milieu following intracutaneous excision axotomy in nine-banded armadillos
4. Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings
5. Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasis
6. Adjuvants
7. Population-based, spatiotemporal modeling of social risk factors and mortality from schistosomiasis in Brazil between 1999 and 2018
8. Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs
9. Serological and molecular detection of infection with Mycobacterium leprae in Brazilian six banded armadillos (Euphractus sexcinctus)
10. Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases
11. Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection
12. Evaluation of a Point-of-Need Molecular Diagnostic Tool Coupled with Rapid DNA Extraction Methods for Visceral Leishmaniasis
13. Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis
14. Correlates of GLA family adjuvants’ activities
15. The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients
16. sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
17. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant
18. Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis
19. Adjuvants
20. Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia
21. Association between asthma, rhinitis and atopic dermatitis with leprosy: A case-control study.
22. Association between asthma, rhinitis and atopic dermatitis with leprosy: A case-control study
23. Interleukin 17A Acts Synergistically With Interferon γ to Promote Protection Against Leishmania infantum Infection
24. Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
25. Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection
26. LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection
27. Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy
28. Screening and identification of immunoactive peptide mimotopes for the enhanced serodiagnosis of tuberculosis
29. Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy
30. Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis
31. Zoonotic leprosy in the Southeastern United States
32. A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
33. Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions
34. Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate
35. NDO-BSA, LID-1, and NDO-LID Antibody Responses for Infection and RLEP by Quantitative PCR as a Confirmatory Test for Early Leprosy Diagnosis
36. The Emergence of Defined Subunit Vaccines for the Prevention of Leishmaniasis
37. Editorial: Emerging Concepts of Innate Immune Responses to Neglected Tropical Diseases
38. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
39. Enhanced humoral and Type 1 cellular immune responses with Fluzone ® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
40. Evaluation of Loopamp™ Leishmania Detection Kit and Leishmania Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh
41. Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions
42. Evaluation of Loopamp™ Leishmania Detection Kit and Leishmania Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh
43. Additional file 1 of The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients
44. Evolution of antigen‐specific immune responses in cutaneous leishmaniasis patients
45. Advances and hurdles on the way toward a leprosy vaccine
46. Use of defined TLR ligands as adjuvants within human vaccines
47. Acceptability of rapid diagnostic tests among patients and their contacts in the Philippines is sustained beyond the completion of treatment
48. Performance of recombinant proteins in diagnosis and differentiation of canine visceral leishmaniasis infected and vaccinated dogs
49. An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
50. Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.